NPS PHARMA INC (NPSP)

Overview Data Buy Sell Hold P&P Help

Quote Price $7.85 Price change for today in $ -0.06 Price change for today in % -0.76 Open Price $7.91 Previous Close $7.91 Daily Range $7.75 - $8.15 52-Week Range $4.35 - $10.33 Volume 559,775     Brokerage Analyst Recommendations  8 Brokerage Firms Covering NPSP   Strong Buy 6 Buy 1 Hold 1 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR):1.38    Description NPS PHARMACEUTICALS INC. is engaged in the discovery and development of orally active, small molecule drugs that target surface receptors and ion channels. Co. is also applying its calcium receptor technology to the development of orally active, small molecule drugs which have neuroprotectant properties and target certain calcium channels in order to provide treatments for stoke, head trauma, chronic pain and epilepsy.   550 HILLS DRIVE BEDMINSTER, NJ 07921, USA Phone: (908) 450-5300 Fax: 908-450-5351 Web: http://www.npsp.com Industry:MED-DRUGS Sector: Medical Fiscal Year End:December Last Reported Quarter:03/31/12 Next EPS Date:08/07/12

Capital Structure Solvency and Cash Flow No comments yet. Be the first

Governance Social Responsibility and Employee Relations No comments yet. Be the first

Acquisitions Divestitures and Joint Ventures No comments yet. Be the first

Recent and Upcoming Events May 22, 2012 13:18 NPS Pharmaceuticals Makes a Move: Down 2.0% May 21, 2012 14:01 NPS Pharmaceuticals Trading Higher on 1.8x Above-Average Volume (NPSP) May 21, 2012 09:38 Earnings Look Back: NPS Pharmaceuticals Is Down 0.4% Since Reporting Quarterly Results 2 Weeks Ago (NPSP) May 21, 2012 08:01 Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (HALO, NPSP, PLX, PCYC, SCLN) May 21, 2012 08:00 Digestive Disease Week Presentations Support Therapeutic Potential for Gattex (teduglutide) as Novel Treatment for Adult Short Bowel Syndrome May 19, 2012 09:34 NPS Pharmaceuticals Earnings Review: 16 Days after Announcement Shares Down 0.4% (NPSP) May 18, 2012 13:14 Shares of NPS Pharmaceuticals Receive a Boost, Up 2.3% May 15, 2012 11:09 Stock Investors Bid Up Shares of NPS Pharmaceuticals, Up 2.7% May 14, 2012 13:08 NPS Pharmaceuticals Earnings Hindsight: Down 2.1% in Last 11 Days (NPSP) May 14, 2012 09:44 NPS Pharmaceuticals Q1 net loss increases May 12, 2012 10:12 Post Earnings Update: NPS Pharmaceuticals Has Sunk 2.1% Lower in Past Week (NPSP) May 10, 2012 11:13 Buyers Accumulate Shares of NPS Pharmaceuticals, Up 2.1% May 04, 2012 14:07 Volume Spike Detected in Shares of NPS Pharmaceuticals as They Move Lower on 1.3x Above-Average Volume (NPSP) May 04, 2012 11:05 Stock Investors Sell Off Shares of NPS Pharmaceuticals, Down 4.7% May 03, 2012 16:30 NPS Pharmaceuticals Reports First Quarter 2012 Financial Results

Major Risks No comments yet. Be the first

---

Created by: WikiMigrationBot. Last Modification: Thursday 03 of June, 2010 08:30:48 CDT by WikiMigrationBot.